 In menopausal hormone therapy, dydrogesterone is administered together with an estrogen.Therefore, the interaction between dydrogesterone and estrogens has been assessed, and no clinically significant interaction has been observed.Dydrogesterone is a highly selective progestogen, and due to its unique structure, unlike progesterone and many other progestins, binds almost exclusively to the progesterone receptor (PR).